Fatty liver breakthrough: A safe, cheap vitamin shows promise

Approximately 30% of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that previously lacked targeted treatments. In a groundbreaking discovery, researchers have identified a genetic factor that exacerbates the disease, and remarkably, the…

Click here to view the original article.